
A biomedical system dynamics approach to anemia management
PhySoftAMS is an individualized drug dosing platform that facilitates significant improvements in anemia and iron management for dialysis services providers.
PhySoftAMS accounts for the complexities of long- and short-acting ESAs and their effect on each patient’s unique response when creating red blood cells (the biological process of erythropoiesis), delivering personalized dosing recommendations that clinicians can trust.
Shown to improve hemoglobin target achievement, reduce dosing variability, and lower ESA usage by nearly 50% in clinical trials and more than a decade of commercial use.

Uses patient history to determine an individual’s hemoglobin response to ESAs, supporting recommendations that help reduce hemoglobin cycling, improve anemia control, and promote stable outcomes over time

Illuminates patient trends through clear graphic visualizations, enabling faster, more informed reviews that enhance efficiency, support clinical judgment, and improve care consistency across patient populations

Provides convenient VPN-secured, HIPAA-compliant access through a browser or API, integrating seamlessly with EMRs to ensure patient data is protected while supporting efficient care delivery

Incorporates established protocols, preferences, and best practices, allowing care teams to benefit from the platform’s precision dosing while maintaining consistency with internal guidelines

Recommends the minimum drug amount needed to maintain patients’ hemoglobin within target ranges, helping reduce drug exposure, minimize waste, and support safer, more efficient anemia management
Managing anemia in dialysis patients is complex—and costly. Clinicians rely on PhySoftAMS to deliver ESA dosing with confidence. Here’s what some of them have to say about us.
Organizational support












